Braun Stacey Associates Inc. lessened its stake in shares of Itron, Inc. (NASDAQ:ITRI – Free Report) by 57.4% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 28,750 shares of the scientific and technical instruments company’s stock after selling 38,679 shares during the quarter. Braun Stacey Associates Inc.’s holdings in Itron were worth $2,577,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Dimensional Fund Advisors LP boosted its position in shares of Itron by 18.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,271,042 shares of the scientific and technical instruments company’s stock valued at $118,034,000 after acquiring an additional 194,768 shares during the period. Geode Capital Management LLC increased its holdings in Itron by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 1,144,982 shares of the scientific and technical instruments company’s stock worth $106,340,000 after acquiring an additional 6,598 shares during the period. First Trust Advisors LP increased its holdings in Itron by 4.1% during the 4th quarter. First Trust Advisors LP now owns 793,175 shares of the scientific and technical instruments company’s stock worth $73,654,000 after acquiring an additional 31,088 shares during the period. Norges Bank purchased a new stake in Itron in the 4th quarter worth approximately $63,990,000. Finally, Arrowstreet Capital Limited Partnership lifted its stake in Itron by 42.5% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 604,580 shares of the scientific and technical instruments company’s stock worth $75,306,000 after purchasing an additional 180,366 shares in the last quarter. 96.19% of the stock is currently owned by institutional investors.
Insider Transactions at Itron
In other news, CFO Joan S. Hooper sold 442 shares of Itron stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total transaction of $37,291.54. Following the completion of the sale, the chief financial officer directly owned 117,478 shares of the company’s stock, valued at approximately $9,911,618.86. The trade was a 0.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP John F. Marcolini sold 322 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total transaction of $27,167.14. Following the completion of the transaction, the senior vice president owned 24,689 shares of the company’s stock, valued at $2,083,010.93. This trade represents a 1.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 3,946 shares of company stock valued at $324,420. Insiders own 1.77% of the company’s stock.
Itron Trading Up 1.1%
Itron (NASDAQ:ITRI – Get Free Report) last released its quarterly earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.23. The business had revenue of $586.98 million during the quarter, compared to analysts’ expectations of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. The business’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Sell-side analysts forecast that Itron, Inc. will post 6.01 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research analysts have commented on ITRI shares. Needham & Company LLC initiated coverage on shares of Itron in a report on Friday, March 6th. They issued a “buy” rating and a $124.00 price target for the company. TD Cowen decreased their price target on shares of Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. JPMorgan Chase & Co. lowered their price objective on Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a research report on Thursday, April 16th. Roth Mkm reissued a “buy” rating and set a $136.00 price objective on shares of Itron in a research note on Wednesday, April 29th. Finally, Stephens restated an “overweight” rating and set a $130.00 target price on shares of Itron in a research report on Wednesday, May 20th. Eight analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Itron has an average rating of “Moderate Buy” and an average target price of $131.22.
View Our Latest Report on Itron
About Itron
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
See Also
- Five stocks we like better than Itron
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Want to see what other hedge funds are holding ITRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Itron, Inc. (NASDAQ:ITRI – Free Report).
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
